Phthalates and risk of endometriosis

Environmental Research

Volumn 126, Issue , 2013, Pages 91-97

  Upson, Kristen ^a,b   Sathyanarayana, Sheela ^a,c,d   De Roos, Anneclaire J ^a,b   Thompson, Mary Lou ^a   Scholes, Delia ^a,e   Dills, Russell ^a   Holt, Victoria L ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^e GROUP HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Endometriosis; Environmental health; Epidemiology; Phthalate; Population based case control study

Indexed keywords

CREATININE; PHTHALIC ACID; PHTHALIC ACID DIETHYL ESTER;

AGE; DATA ACQUISITION; DISEASE; ENDOCRINE DISRUPTOR; EPIDEMIOLOGY; FEMALE; HEALTH CARE; HEALTH RISK; METABOLITE; PHTHALATE;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; CONTRACEPTIVE BEHAVIOR; CONTROLLED STUDY; CREATININE URINE LEVEL; ENDOMETRIOSIS; ENVIRONMENTAL EXPOSURE; EXPOSURE VARIABLE; FAMILY HISTORY; FEMALE; HEALTH CARE SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY CONCENTRATING CAPACITY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCTIVE HISTORY; RISK ASSESSMENT; SMOKING; TANDEM MASS SPECTROMETRY; URINALYSIS;

PACIFIC NORTHWEST;

BENZYL BUTYL PHTHALATE; BMI; BODY MASS INDEX; BZBP; CI; CONFIDENCE INTERVAL; DAG; DBP; DEHP; DEP; DI-(2-ETHYLHEXYL) PHTHALATE; DIBUTYL PHTHALATE; DIETHYL PHTHALATE; DIRECTED ACYCLIC GRAPH; ENDOMETRIOSIS; ENVIRONMENTAL HEALTH; EPIDEMIOLOGY; GEOMETRIC MEAN; GH; GM; GROUP HEALTH; LIMIT OF QUANTITATION; LOQ; MBZP; MECPP; MEHHP; MEHP; MEOHP; MEP; MIBP; MNBP; MONO-(2-ETHYL-5-CARBOXYPENTYL) PHTHALATE; MONO-(2-ETHYL-5-HEXYL) PHTHALATE; MONO-(2-ETHYL-5-HYDROXYHEXYL) PHTHALATE; MONO-(2-ETHYL-5-OXOHEXYL) PHTHALATE; MONO-BENZYL PHTHALATE; MONO-ETHYL PHTHALATE; MONO-ISO-BUTYL PHTHALATE; MONO-N-BUTYL PHTHALATE; NATIONAL HEALTH AND NUTRITION AND EVALUATION SURVEY; NHANES; ODDS RATIO; OR; PERSISTENT ORGANIC POLLUTANTS AND ENDOMETRIOSIS RISK STUDY; PHTHALATE; POPS; POPULATION-BASED CASE-CONTROL STUDY; WOMEN'S RISK OF ENDOMETRIOSIS STUDY; WREN;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; ENDOCRINE DISRUPTORS; ENDOMETRIOSIS; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MIDDLE AGED; NORTHWESTERN UNITED STATES; PHTHALIC ACIDS; YOUNG ADULT;

EID: 84885852114     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2013.07.003     Document Type: Article

References (55)

1. Adibi J.J., et al. Characterization of phthalate exposure among pregnant women assessed by repeat air and urine samples. Environ. Health Perspect 2008, 116:467-473.
2. ATSDR, 1995. Toxicological Profile for Diethyl Phthalate. Agency for Toxic Substances and Disease Registry. U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA.
3. ATSDR, 2001. Toxicological profile for Di-n-Butyl Phthalate. Agency for Toxic Substances and Disease Registry. U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA.
4. ATSDR, 2002. Toxicological profile for Di(2-EthylHexyl) Phthalate Agency for Toxic Substances and Disease Registry. U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA.
5. Baird D.D., et al. Within-person variability in urinary phthalate metabolite concentrations: measurements from specimens after long-term frozen storage. J. Expo. Sci. Environ. Epidemiol. 2010, 20:169-175.
6. Barr D.B., et al. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ. Health Perspect. 2005, 113:192-200.
7. Bulun S.E. Endometriosis. N. Engl. J. Med. 2009, 360:268-279.
8. CDC, 2009. Fourth National Report on Human Exposure to Environmental Chemicals. Centers for Disease Control and Prevention, Atlanta, GA.
9. CDC, 2012. Fourth National Report on Human Exposure to Environmental Chemcials. Updated Tables, February 2012. Centers for Disease Control and Prevention, Atlanta, GA.
10. CERHR, 2003. NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Butyl Benzyl Phthalate (BBP). NTP CERHR MON. pp. i-III90.
11. Cobellis L., et al. High plasma concentrations of di-(2-ethylhexyl)-phthalate in women with endometriosis. Hum. Reprod. 2003, 18:1512-1515.
12. Coldham N.G., et al. Evaluation of a recombinant yeast cell estrogen screening assay. Environ. Health Perspect. 1997, 105:734-742.
13. Davis B.J., et al. Di-(2-ethylhexyl) phthalate suppresses estradiol and ovulation in cycling rats. Toxicol. Appl. Pharmacol. 1994, 128:216-223.
14. ECB, 2007. European Union Risk Assessment Report for Benzyl Butyl Phthalate (BBP). European Chemicals Bureau, Ispra, Italy. vol. 76.
15. ECB, 2008. European Union Risk Assessment Report for Bis(2-Ethylhexyl) Phthalate (DEHP). European Chemicals Bureau, Ispra, Italy. vol. 80.
16. Eskenazi B., Warner M.L. Epidemiology of endometriosis. Obstet. Gynecol. Clin. North Am. 1997, 24:235-258.
17. FDA Safety assessment of di(2-ethylhexyl)phthalate (DEHP) released from PVC medical devices Center for Devices and Radiological Health 2001, U.S. Food and Drug Administration, Rockville, MD.
18. Fromme H., et al. Occurrence and daily variation of phthalate metabolites in the urine of an adult population. Int. J. Hyg. Environ. Health 2007, 210:21-33.
19. Giudice L.C., Kao L.C. Endometriosis. Lancet 2004, 364:1789-1799.
20. Greenland S., et al. Causal diagrams for epidemiologic research. Epidemiology 1999, 10:37-48.
21. Gupta R.K., et al. Di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate inhibit growth and reduce estradiol levels of antral follicles in vitro. Toxicol. Appl. Pharmacol. 2010, 242:224-230.
22. Harris C.A., et al. The estrogenic activity of phthalate esters in vitro. Environ. Health Perspect. 1997, 105:802-811.
23. Hernan M.A., et al. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am. J. Epidemiol. 2002, 155:176-184.
24. Holt V.L., Weiss N.S. Recommendations for the design of epidemiologic studies of endometriosis. Epidemiology 2000, 11:654-659.
25. Huang P.C., et al. Association between phthalate exposure and glutathione S-transferase M1 polymorphism in adenomyosis, leiomyoma and endometriosis. Hum. Reprod. 2010, 25:986-994.
26. IPCS Benzyl Butyl Phthalate. Concise International Chemical Assessment Document 17. International Programme on Chemical Safety 1999, World Health Organization, Geneva.
27. IPCS Diethyl Phthalate. Concise International Chemical Assessment Document 2003, 52. International Programme on Chemical Safety, World Health Organization, Geneva, Switzerland.
28. Itoh H., et al. Urinary phthalate monoesters and endometriosis in infertile Japanese women. Sci. Total Environ. 2009, 408:37-42.
29. Jobling S., et al. A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ. Health Perspect. 1995, 103:582-587.
30. Kato K., et al. Quantitative detection of nine phthalate metabolites in human serum using reversed-phase high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. J. Anal. Toxicol. 2003, 27:284-289.
31. Kavlock R., et al. NTP center for the evaluation of risks to human reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di-n-butyl phthalate. Reprod. Toxicol. 2002, 16:489-527.
32. Kavlock R., et al. NTP center for the evaluation of risks to human reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di(2-ethylhexyl) phthalate. Reprod. Toxicol. 2002, 16:529-653.
33. Kim S.H., et al. Increased plasma levels of phthalate esters in women with advanced-stage endometriosis: a prospective case-control study. Fertil. Steril. 2011, 95:357-359.
34. Koch H.M., Calafat A.M. Human body burdens of chemicals used in plastic manufacture. Philos. Trans. R. Soc. London B Biol. Sci. 2009, 364:2063-2078.
35. Lamb J.C.t., et al. Reproductive effects of four phthalic acid esters in the mouse. Toxicol. Appl. Pharmacol. 1987, 88:255-269.
36. Li, N., et al., 2012. Di-(2-ethylhcxyl) phthalate reduces progesterone levels and induces apoptosis of ovarian granulosa cell in adult female ICR mice. Environ. Toxicol. Pharmacol.
37. Lubin J.H., et al. Epidemiologic evaluation of measurement data in the presence of detection limits. Environ. Health Perspect. 2004, 112:1691-1696.
38. Marino J.L., et al. Shift work, hCLOCK T3111C polymorphism, and endometriosis risk. Epidemiology 2008, 19:477-484.
39. Marino J.L., et al. Lifetime occupational history and risk of endometriosis. Scand. J. Work Environ. Health. 2009, 35:233-240.
40. Okubo T., et al. Estimation of estrogenic and anti-estrogenic activities of some phthalate diesters and monoesters by MCF-7 cell proliferation assay in vitro. Biol. Pharm. Bull. 2003, 26:1219-1224.
41. Peck J.D., et al. Intra- and inter-individual variability of urinary phthalate metabolite concentrations in Hmong women of reproductive age. J. Expo. Sci. Environ. Epidemiol. 2010, 20:90-100.
42. Reddy B.S., et al. Association of phthalate esters with endometriosis in Indian women. Bjog 2006, 113:515-520.
43. Reddy B.S., et al. High plasma concentrations of polychlorinated biphenyls and phthalate esters in women with endometriosis: a prospective case control study. Fertil. Steril. 2006, 85:775-779.
44. Reinsberg J., et al. Effect of mono-(2-ethylhexyl) phthalate on steroid production of human granulosa cells. Toxicol. Appl. Pharmacol. 2009, 239:116-123.
45. Silva M.J., et al. Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ. Health Perspect. 2004, 112:331-338.
46. Silva M.J., et al. Quantification of 22 phthalate metabolites in human urine. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2007, 860:106-112.
47. Soto A.M., et al. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ. Health Perspect. 1995, 103(Suppl 7):113-122.
48. Takai R., et al. Collaborative work on evaluation of ovarian toxicity. 10) Two- or four-week repeated dose studies and fertility study of di-(2-ethylhexyl) phthalate (DEHP) in female rats. J. Toxicol. Sci. 2009, 34(Suppl 1):SP111-SP119.
49. Teitelbaum S.L., et al. Temporal variability in urinary concentrations of phthalate metabolites, phytoestrogens and phenols among minority children in the United States. Environ. Res. 2008, 106:257-269.
50. Trabert B., et al. Non-dioxin-like polychlorinated biphenyls and risk of endometriosis. Environ. Health. Perspect. 2010, 118:1280-1285.
51. Ulukus M., et al. The role of endometrium in endometriosis. J. Soc. Gynecol. Invest. 2006, 13:467-476.
52. Weuve J., et al. Association of exposure to phthalates with endometriosis and uterine leiomyomata: findings from NHANES, 1999-2004. Environ. Health Perspect. 2010, 118:825-832.
53. Wittassek M., et al. Assessing exposure to phthalates-the human biomonitoring approach. Mol. Nutr. Food Res. 2011, 55:7-31.
54. Wormuth M., et al. What are the sources of exposure to eight frequently used phthalic acid esters in Europeans?. Risk Anal. 2006, 26:803-824.
55. Zacharewski T.R., et al. Examination of the in vitro and in vivo estrogenic activities of eight commercial phthalate esters. Toxicol. Sci. 1998, 46:282-293.